New cancer research proposes a promising future
share
Earlier this month, the National Cancer Institute (NCI) of the National Institutes of Health (NIH) published a press release concerning the usage of fecal transplants to augment immunotherapy in advanced skin cancer patients. According to the NCI, patients with advanced melanoma responded more favorably to immunotherapy drugs after receiving a transplant of fecal microbiota from other drug responders.
“Our study is one of the first to demonstrate in patients that altering the composition of the gut microbiome can improve the response to immunotherapy,” said Giorgio Trinchieri, chief of the Laboratory of Integrative Cancer Immunology at the NCI. “The data provides proof of concept that the gut microbiome can be a therapeutic target in cancer.”
Small-scale test involving biosensor and trained algorithms shows early promise
Katyanna Quach Wed 27 Jan 2021 // 06:34 UTC Share
Copy
Scientists say they have devised a way to screen for prostate cancer using a drop of urine, a sensor, and AI algorithms. And the test takes just twenty minutes, and is 99 per cent accurate, according to results from a small-scale test.
The risk of developing prostate cancer increases for men as they get older, and the over 50s are supposed to be routinely screened for the disease. If the examination – performed either with a blood test or something. more hands on – suggests there s a problem, the patient may undergo a biopsy, where a small amount of tissue is extracted from the prostate to confirm whether or not there are cancerous cells present. But these screening tests tend to generate a lot of false positives, leading to unnecessary biopsies.
This AI-based technique can detect prostate cancer from urine IANS
Seoul: A novel Artificial Intelligence (AI)-based technique may help in diagnosing prostate cancer from urine within only twenty minutes with almost 100 per cent accuracy, a new study suggests.
The research team, including Kwan Hyi Lee from the Korea Institute of Science and Technology (KIST), developed this technique by introducing a smart AI analysis method to an electrical signal-based ultra-sensitive biosensor.
“This research developed a smart biosensor that can rapidly diagnose prostate cancer with almost 100 per cent accuracy only through a urine test, and it can be further utilized in the precise diagnoses of other cancers using a urine test,” said Lee.
A novel Artificial Intelligence (AI)-based technique may help in diagnosing prostate cancer from urine within only twenty minutes with almost 100 per cent accuracy, a new study suggests.The research team, including Kwan Hyi Lee from the Korea .
New technique can rapidly diagnose prostate cancer from urine
Prostate cancer is one of the most common cancers among men. Patients are determined to have prostate cancer primarily based on PSA, a cancer factor in blood. However, as diagnostic accuracy is as low as 30%, a considerable number of patients undergo additional invasive biopsy and thus suffer from resultant side effects, such as bleeding and pains.
The Korea Institute of Science and Technology (KIST) announced that the collaborative research team led by Dr. Kwan Hyi Lee from the Biomaterials Research Center and Professor In Gab Jeong from Asan Medical Center developed a technique for diagnosing prostate cancer from urine within only twenty minutes with almost 100% accuracy. The research team developed this technique by introducing a smart AI analysis method to an electrical-signal-based ultrasensitive biosensor.